Tags: Drug.

Thymectacin (NB-1011 NB-101 N-[[5-[(E)-2-Bromovinyl]-2′-deoxyuridin-5′-O-yl]](phenoxy)phosphoryl]-L-alanine methyl ester) is an anticancer prodrug of brivudine monophosphate. It developed by New Biotics and it has entered in phase I clinical trials for colon cancer.

Thymectacin.svg
CAS number
232925-18-7
IUPAC name
(2S)-methyl 2-((((2R3S5R)-5-(5-((E)-2-bromovinyl)-24-dioxo-34-dihydropyrimidin-1(2H)-yl)-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphorylamino)propanoate
PubChem
6440764

Loading...

This page contains content from the copyrighted Wikipedia article "Thymectacin"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.